Rotate your device

Please rotate your device to landscape mode
for the best experience.

Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darbecure 40 Injection

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Darbepoetin alfa (40mcg)

Overview Darbecure 40 Injection

Erythropoiesis-stimulating agent Darbecure 40 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Due to potential serious adverse effects, administration requires rigorous caution and oversight by a qualified hematologist. Strict adherence to the physician's instructions is mandatory, as this medication is administered only under professional medical supervision. Frequently reported side effects encompass abdominal discomfort, hypertension, cutaneous eruptions, injection site pain, dyspnea, cough, and peripheral swelling. Report immediately any signs of severe hypertension, such as intense headache, visual disturbances, emesis, nausea, or convulsions. Regular blood tests, monitoring electrolyte levels (potassium), hemoglobin, and blood cell counts, are typically ordered by the prescribing physician. Discontinue use and seek immediate medical attention if shortness of breath or a skin rash develops. Prior to initiating therapy, disclose any pre-existing cardiac conditions, hypertension, history of seizures or stroke. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals must consult their physician regarding the medication's safety profile.

Uses of Darbecure 40 Injection

Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia

Major Benefits of Darbecure 40 Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Darbecure 40 Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darbecure 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Darbecure 40 Injection works:

Darbecure 40 Injection, an erythropoietin-based medication, boosts red blood cell production. This action occurs through stimulation of the bone marrow, the blood cell-generating tissue within bones.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Darbecure 40 Injection may be unsafe; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Darbecure 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Limited evidence indicates that Darbecure 40 Injection may pose a risk to breastfeeding infants. The drug's potential transfer into breast milk, and consequent harm to the baby, necessitates caution.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darbecure 40 Injection.

KidneyKidneySAFE IF PRESCRIBED

Darbecure 40 Injection poses no safety concerns for patients with kidney impairment; no dosage modification is necessary.

LiverLiverCAUTION

For individuals with hepatic impairment, Darbecure 40 Injection requires careful administration. Dosage modification of Darbecure 40 Injection might be necessary. Physician consultation is advised.

What if you forget to take Darbecure 40 Injection :

Should you forget a Darbecure 40 Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Darbecure 40 Injection

LabelValue
Chemical Category Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Behavior Class Erythropoietin-stimulating drug

FAQs on Darbecure 40 Injection

Within 2 to 6 weeks of beginning Darbecure 40 Injection, you should see a rise in your red blood cell count (hemoglobin levels). Consult your doctor with any questions or concerns.
Darbecure 40 Injection requires careful administration due to potentially serious, even life-threatening, side effects. Expert medical supervision from a physician experienced with Darbecure 40 Injection therapy is crucial. Strictly adhere to all prescribed instructions.
Darbecure 40 Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; addressing these deficiencies is crucial. Treatment failure may also result from bleeding, infections, inflammation, or bone marrow fibrosis. Consult your doctor for further guidance.
Darbecure 40 Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children mirror those observed in adults. Consult your doctor for any concerns.
Darbecure 40 Injection can influence blood pressure. Regular blood pressure monitoring is essential, especially during initial treatment. Patients with hypertension should manage their blood pressure appropriately. Treatment with Darbecure 40 Injection may be discontinued if blood pressure remains uncontrolled.
Darbecure 40 Injection should only be used under a doctor's prescription. It is contraindicated for individuals with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Darbecure 40 Injection or similar drugs, or a history of serious allergic reactions to this medication.
Darbecure 40 Injection
2,485
MRP 2,876
13% off